IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q3 2018 Holdings

Filed 2018-11-14 | 3 holdings | $7.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Onconova Therapeutics IncCOM PAR68232V405$6.0K816,27275.6%
MMA Cap Mgmt LLC(MMAC)COM55315D105$1.9K72,55224.0%
Onconova Therapeutics Inc*W EXP 07/11/20268232V116$39390,6240.5%